Table 3 Baseline characteristics of the study population based on coronary atherosclerosis severity

Age(years)

55.41 ± 9.28

61.35 ± 9.20

62.78 ± 9.08

66.76 ± 9.85

< 0.01

Male, n (%)

57(35%)

109(51%)

56(62%)

46(59%)

< 0.01

Family history, n(%)

20(12%)

26(12%)

14(16%)

15(19%)

0.41

Smoking, n (%)

46(28%)

93(44%)

50(56%)

43(55%)

< 0.01

DM, n (%)

25(15%)

60(28%)

45(50%)

34(44%)

< 0.01

HT, n (%)

85(52%)

157(74%)

67(74%)

67(86%)

< 0.01

HGB (g/L)

135.33 ± 15.87

136.52 ± 14.30

138.84 ± 17.09

133.88 ± 16.63

0.18

Platelet (10⁹/L)

221.32 ± 51.31

215.01 ± 53.60

206.66 ± 57.82

205.73 ± 46.94

0.08

Leukocyte (10⁹/L)

6.07(4.99–7.13)

6.41(5.36–7.50)

6.92(6.00–8.18)

6.67(5.80–8.08)

< 0.01

Neutrophil (10⁹/L)

3.42(2.95–4.41)

3.90(3.20–4.63)

4.73(3.81–5.49)

4.67(3.80–5.70)

< 0.01

Monocyte (10⁸/L)

3.02(2.51–3.62)

3.52(3.04–4.38)

4.24(3.36–4.92)

4.81(3.56–5.62)

< 0.01

Lymphocyte (10⁹/L)

1.95(1.49–2.29)

1.84(1.46–2.28)

1.70(1.37–2.06)

1.37(1.10–1.91)

< 0.01

FBG (mmol/L)

5.35(4.93–5.88)

6.04(5.27–7.24)

6.74(5.53–9.41)

6.34(5.56–8.15)

< 0.01

TC (mmol/L)

4.84 ± 1.10

5.03 ± 1.10

4.88 ± 1.19

5.04 ± 1.13

0.35

TG (mmol/L)

1.51(1.06–2.23)

1.57(1.17–2.30)

1.47(1.12–2.31)

1.42(1.04–2.19)

0.34

LDL (mmol/L)

2.65(2.12–3.25)

2.76(2.23–3.35)

2.57(2.09–3.44)

2.88(2.29–3.48)

0.40

HDL (mmol/L)

1.16(0.94–1.39)

1.09(0.92–1.29)

1.04(0.92–1.27)

1.15(0.90–1.31)

0.12

SCr (μmol/L)

71.34(59.27–83.51)

73.36(62.94–86.25)

79.35(65.35–92.30)

81.64(65.85–92.96)

< 0.01

UA (μmol/L)

334.12 ± 93.41

331.93 ± 88.51

335.62 ± 88.79

345.44 ± 102.95

0.74

NLR

1.87(1.42–2.36)

2.09(1.64–2.77)

2.73(2.24–3.34)

3.37(2.50–4.75)

< 0.01

MLR

0.16(0.13–0.21)

0.20(0.15–0.25)

0.23(0.19–0.31)

0.29(0.21–0.43)

< 0.01